NC
ISEE

NewSquare Capital’s IVERIC bio, Inc. Common Stock ISEE Stock Holding History

NewSquare Capital’s Portfolio ISEE Stock Details ISEE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-100
Closed -$1K – 373
2020
Q4 		$1K Hold
100
– – ﹤0.01% 326
2020
Q3 		$1K Hold
100
– – ﹤0.01% 324
2020
Q2 		$1K Hold
100
– – ﹤0.01% 363
2020
Q1 		$0 Hold
100
– – ﹤0.01% 410
2019
Q4 		$1K Hold
100
– – ﹤0.01% 302
2019
Q3 		$0 Hold
100
– – ﹤0.01% 371
2019
Q2 		$0 Hold
100
– – ﹤0.01% 376
2019
Q1 		$0 Hold
100
– – ﹤0.01% 359
2018
Q4 		$0 Buy
+100
New +$194 ﹤0.01% 367

Other funds holding ISEE

ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
YCM
Yiheng Capital Management San Francisco, California $231M AUM 29.07% 1-Year Est. Return

NewSquare Capital's ISEE Position: Q1 2021 in Review

NewSquare Capital sold out of IVERIC bio, Inc. Common Stock (ISEE) in Q1 2021, closing a stake of 100 shares — an estimated $1K sold.

NewSquare Capital first reported a position in ISEE in Q4 2018 and held it in 9 quarters. The position peaked at $1K in Q4 2020. 115 funds tracked by Wall St. Rank hold ISEE as of Q1 2021.

  • NewSquare Capital reported no remaining IVERIC bio, Inc. Common Stock position as of Q1 2021 after selling out during the quarter.
  • NewSquare Capital sold 100 IVERIC bio, Inc. Common Stock shares in Q1 2021, an estimated $1K.
  • NewSquare Capital first reported a position in IVERIC bio, Inc. Common Stock in Q4 2018 and held it in 9 quarters.
  • NewSquare Capital's IVERIC bio, Inc. Common Stock position peaked at $1K in Q4 2020.
  • 115 funds tracked by Wall St. Rank held IVERIC bio, Inc. Common Stock as of Q1 2021.

Based on NewSquare Capital's 13F filing for Q1 2021, filed 10 May 2021.